Taking a look at what insiders are doing to gauge the Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s direction
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,048,119 were sold by Kalif Eliyahu Sharon on Mar 06 ’24. At $13.52 per share, Kalif Eliyahu Sharon sold 77,550 shares. The insider’s holdings dropped to 203,691 shares worth […]
Keeping an Eye on Teva- Pharmaceutical Industries Ltd. ADR (TEVA) After Insider Trading Activity
Teva- Pharmaceutical Industries Ltd. ADR’s recently made public that its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for reported $1.05 million on Mar 06 ’24. In the deal valued at $13.52 per share,77,550 shares were sold. As a result of this transaction, Kalif Eliyahu Sharon now holds 203,691 shares worth roughly $2.62 […]
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Records 50-Day SMA of $13.41
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,048,119 were sold by Kalif Eliyahu Sharon on Mar 06 ’24. At $13.52 per share, Kalif Eliyahu Sharon sold 77,550 shares. The insider’s holdings dropped to […]
Monitoring Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insider movements
Teva- Pharmaceutical Industries Ltd. ADR’s recent filing unveils that its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for reported $1.05 million on Mar 06 ’24. In the deal valued at $13.52 per share,77,550 shares were sold. As a result of this transaction, Kalif Eliyahu Sharon now holds 203,691 shares worth roughly $2.71 […]
Days-to-cover ratio for TEVA declines to 1.17 due to decline in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,048,119 were sold by Kalif Eliyahu Sharon on Mar 06 ’24. At $13.52 per share, Kalif Eliyahu Sharon sold 77,550 shares. The insider’s […]
Monitoring Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insider movements
In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for reported $1.05 million on Mar 06 ’24. In the deal valued at $13.52 per share,77,550 shares were sold. As a result of this transaction, Kalif Eliyahu Sharon now holds 203,691 shares worth roughly $2.9 […]
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Records 50-Day SMA of $13.08
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,048,119 were sold by Kalif Eliyahu Sharon on Mar 06 ’24. At $13.52 per share, Kalif Eliyahu Sharon sold 77,550 shares. The insider’s holdings dropped to 203,691 shares worth […]
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] stock was sold by Kalif Eliyahu Sharon at the price of US$1.05 million
Teva- Pharmaceutical Industries Ltd. ADR’s recent filing unveils that its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for reported $1.05 million on Mar 06 ’24. In the deal valued at $13.52 per share,77,550 shares were sold. As a result of this transaction, Kalif Eliyahu Sharon now holds 203,691 shares worth roughly $2.87 […]
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Insider Activity: An Update for Investors
Teva- Pharmaceutical Industries Ltd. ADR’s recent filing unveils that its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for reported $1.05 million on Mar 06 ’24. In the deal valued at $13.52 per share,77,550 shares were sold. As a result of this transaction, Kalif Eliyahu Sharon now holds 203,691 shares worth roughly $2.86 […]
Teva Pharmaceutical (TEVA) revised its financial forecast after low third-quarter sales
Teva Pharmaceutical (TEVA) announced its financial results on Thursday reporting low third-quarter sales and the company reduce its full-year revenue figures. Teva reported 58 cents per share income for the quarter ended September 30, 2020, which is in line with the analyst’s estimates. The earing remains flat over the year. The company sales declined by 2.8% […]
